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a b s t r a c t
Brucellosis is worldwide a zoonotic infective disease especially seen in developing countries.
Frequently it is transmitted to humans through the consumption of products derived from
unpasteurized milk and through direct contact with infected animal tissue. Although the
disease leads to many complications, cardiovascular involvement that is seen in less than
2% of cases usually manifests itself in clinical practice as endocarditis. Endocarditis is
diagnosed lately in the course of the disease with mostly aorta valve involvement and leads
to serious morbidity and mortality. Here we present a case report and literature review on
brucella endocarditis which is a rare but serious clinical condition.
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All rights reserved.
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.Introduction
Although brucellosis is a worldwide frequent infection, it is
much less diagnosed and reported. The most important reason
for this discrepancy is that brucellosis can easily be overlooked
by physician in daily practice. Human brucellosis is caused by
generally one of three brucella species: Brucella melitensis,
Brucella abortus and Brucella suis [1]. Brucellosis is a zoonotic
disease transmitted to humans through the consumption of
products derived from unpasteurized milk and through direct
contact with infected animal remains. Individuals who have
regular contact with livestock and their products, slaughter-
house workers, veterinary staff and shepherds, as well as
people working in microbiology laboratories, who become
infected through inhalation of aerosolized particles, are under
risk [2]. The disease is endemic at Mediterranean region,* Corresponding author. Tel.: +90 342 3606060, +90 342 3676286; fax: +9
E-mail address: mhayrialici@hotmail.com (H. Alici).
http://dx.doi.org/10.1016/j.crvasa.2013.11.001
0010-8650/# 2013 The Czech Society of Cardiology. Published by ElseMiddle East, South Asia and Mid-South America [3]. Brucella
endocarditis is rare in western countries where the infective
agent is B. abortus which leads to moderate disease and
uncommon supportive and disabling complications. However
in countries where B. melitensis, which leads to more severe
disease and disabling symptoms, and rheumatoid cardiac
disease prevalence is higher, brucella endemic infective
endocarditis is seen as an endemic disease [4].
In a literature review which investigated cases of brucellosis
in Turkey between the years of 1990 and 2009, and brucella
endocarditis was observed in 51 of 4204 patients [5]. It is more
frequent in men than women [6]. It has a much higher mortality
rate than endocarditis caused by other pathogens due to its
rapid and wide tissue destruction. The high mortality rate might
be due to late diagnosis of the infection, because due to the
clinical presentation various diseases such as some malignan-
cies might be considered primarily instead of brucellosis.0 342 3603928.
vier Urban & Partner Sp. z o.o. All rights reserved..
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A 32-year-old man was admitted to hospital due to fever and
8 kg weight loss for six months. He was working in a farm
which includes cowshed. He did not have a history of cardiac
disease. His body temperature was 38.3 8C and diastolic
murmur of grade 3/6 at aortic area was found on physical
examination. In transthoracic echocardiography examination,
active vegetation was present on aortic valve (Fig. 1). Brucella
agglutination tests (Rose-Bengal and Wright) were studied in
serum sample. Both Rose-Bengal and Wright tests (the latter in
a titer of 1/640) were positive. A heart valve operation was
planned-following a 6-week antibiotic therapy with rifampicin
and doxycycline with a combination of streptomycin for 3
weeks. Brucella melitensis was isolated from blood culture
drawn on admission. Patient underwent a successful aortic
valve replacement surgery and doxycycline and rifampicin
therapy was continued 6 months after surgery.
Symptoms and ﬁnding
In humans, brucellosis is a multi-systemic disease that is
manifested in a wide variety of ways, the most common form
of presentation being fever of unknown origin, together with
constitutional symptoms such as asthenia, sweating and joint
pain. Approximately 25–35% of brucellosis cases present with
focal complications, affecting at most the osteo-articular
apparatus [2]. A signiﬁcant portion of the patients with
infective endocarditis may present in addition to non-speciﬁc
symptoms such as fever, fatigue, dyspnea, night sweating, loss
of appetite and weight, classical heart failure symptoms such
as dyspnea, palpitation and early tiredness. Despite usual
causes of infective endocarditis, patients with brucellosis
usually suffer from symptoms for 6–12 months. Fever is the
most common ﬁnding. Additionally, new onset or increased
cardiac murmur is considerably signiﬁcant for endocarditis.
Although not speciﬁc to brucella endocarditis, arthritis,Fig. 1 – On transthoracic echocardiography, parasternal long
axis view showing a large vegetation on aortic valve in a
case of brucella infective endocarditis.splenomegaly, petechia, roth spots, Osler nodules, Janeway
lesions, splinter hemorrhage, ﬁnger clubbing may be present.
Diagnosis
The diagnosis of brucella infective endocarditis requires
isolation of bacteria in blood or tissue culture with modiﬁes
Duke criteria or identifying Brucella with serological tests.
Etiological diagnosis is not easy; it requires a high level of
suspicion and is based on the association of epidemiological
data with serological test results and isolation of Brucella in
previously collected blood or tissue samples. The sensitivity of
blood cultures is extremely variable (15–70%) [2,7,8]. The reason
for this variability is the time elapsed between symptoms onset
and diagnosis, previous recent antibiotic therapy and culture
conditions such as culture medium and incubation time. While
positivity of blood culture in Brucella infection is between 15%
and 70%, in Brucella infective endocarditis this rate is above 80%
[9,10]. Brucella is an organism with slow grow rate, which
requires a special environment for growth. It is important to
obtain the blood culture sample before the start of antibiotic
therapy, however even during current antibiotic therapy blood
culture sample should be collected [7,8]. Even in patients under
antibiotic therapy in vegetative cultures bacterial growth can be
detected [9]. Serological methods are more sensitive but have
lower speciﬁcity. Wright agglutination titer 1/160 and over is
very sensitive and speciﬁc for diagnosis of brucellosis [8].
Especially the difﬁculty of interpreting results in endemic
regions and late or absent seroconversion in some patients
limits it's usage [3,7].
Transthoracic echocardiography plays a crucial role in
diagnosing cardiac complications. A trans-esophageal ap-
proach may be required in some cases. The aortic valve is most
frequently affected, however mitral valve involvement is more
common in cases with previous structural changes such
rheumatic valve disease. The most common echocardiograph-
ic ﬁndings are large vegetation, ulcerations and abscesses, but
any structural element of the affected valve may be involved.
In prosthesis valve involvement complication such as bulky
vegetation, para-valvular leakage, aneurysm, abscess and
valve malfunction can be present [11]. The most frequent
complication is congestive heart failure, with an incidence of
75–90%. It has a similar rate of embolic events that seen in
endocarditis caused by other microbiological agents [4,12].
Treatment
There is considerable uncertainty and controversy regarding
appropriate treatment for this clinical entity which leads to
signiﬁcant morbidity and mortality. There is no available clear
data with regard of the most effective antibiotic regimen and
their durations, and the role and timing of surgical treatment.
Given the intracellular nature of Brucella which makes most
commonly used antibiotics ineffective and the degree of tissue
destruction, some authors recommend early surgical valve
replacement combined with pre- and postoperative antibiotic
therapy [7]. However more recently, some authors have rejected
the suggestion that valve replacement is always required. They
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based on long-term combined antibiotics therapy. Cohen et al.
described several series of patients with brucella endocarditis
treated conservatively, with similar outcomes to those obtained
with early surgical intervention as long as there was no heart
failure, valve damage or valve prosthesis [13]. Another literature
review compared clinical features of medically and surgically
treated patients and showed that cardiac failure, abscess and
massive valve damage are predictive factors for invasive
approach [12]. As for the prosthesis valve infections, treatments
of cardiac device infections due to brucella are surgical [14].
Antibiotic therapy is advisable to continue 6 months after
surgery [15] A short time interval between disease onset and
initiation of appropriate antibiotic therapy appears to be
associated with a favorable clinical course [7]. The most
effective regime and duration of antibiotic therapy have not
been fully determined, although it is clear that a combination of
antibiotic agents for prolonged periods is necessary. Prevailing
opinion is a combination therapy with doxycycline and
rifampicin for 8–12 weeks, together with an aminoglycoside
for the ﬁrst 4 weeks of the treatment. In a meta-analysis it was
demonstrated that drugs such as trimethoprim-sulfamethoxa-
zole, quinolones or streptomycin combined with doxycycline,
have lower recurrence rates compared to rifampicin [16] In a
recent study published in this issue in Turkey, IV ceftriaxone or
aminoglycoside therapy is emphasized as a good option at the
beginning of treatment [17].
Conclusion
Brucellosis is a disease which is usually under- and lately
diagnosed disease. A serious suspicion and clinical story is
needed to not overlook the rare complication of infective
endocarditis. Blood culture and serology are important for
diagnosis. Echocardiogram is important for the diagnosis and
follow-up of complications such as vegetation, abscess,
ulceration, prosthesis valve malfunction and cardiac failure
associated with infective endocarditis. While the treatment of
conditions such as prosthesis valve and other intracardiac
device infections, serious valve damage and cardiac failure are
deﬁnitely surgical, in less severe cases where these complica-
tion do not exist and in patients for whom surgical treatment is
considered, pre- and post-operative combined antibiotics
therapy is essential for the treatment.
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